Duration: 1.10.2020 – 30.6.2021
Project coordinator: Ideklinikken, Aalborg University Hospital
Project partners: Turku Science Park Ltd, University of Turku, Labmaster Oy, Tartu BT Park OÜ, BioCon Valley® GmbH, Wroclaw Technology Park, Dianox APS and EATIS.
Funding: Project is funded by Interreg Baltic Sea Region with a total budget of 755 000 €.
Project in a nutshell: Only a small fraction of all biomarker inventions progress to a commercial product: a diagnostic test for clinical use. The BIC (Biomarker Commercialization, 2017-2020) project aimed to promote the commercialization of these inventions and developed tools for researchers, supporting especially the early stages of product development. The BIC BRIDGE follow-up project complements the biomarker commercialization tools developed in the BIC project: develops guidance on the final stages of commercialization and product launch (TRL7-TRL9), identifies necessary training packages (business skills, quality systems, etc.), and describes a biomarker commercialization roadmap, based on the newest EU guidelines. The results of the project will be beneficial for companies, researchers, and technology transfer offices.
Labmaster's role in the project: Development of the “Technical and Clinical Evaluation” and “Commercial Evaluation” tracks for the Phases “6. Industrial assay development” and “7. Commercial launch and clinical implementation”.
Further information: https://biomarker.nu/ Watch the video: BIC BRIDGE Introduction Contact person in Labmaster Ltd: konstantin.denessiouk@labmaster.fi